Collectively, these findings suggest that STING plays a detrimental role in the pathogenesis of MASLD/MASH, with cGAS-STING pathway activation primarily occurring in non-parenchymal cells, particularly hepatic macrophages, contributing to their pro-inflammatory effects. The gene discussed is STING1; the disease is metabolic dysfunction-associated steatotic liver disease.